Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 3.61 +0.76 (26.67%)
Previous Close $2.85    52 Week High
Open $2.85    52 Week Low
Day High $3.66    P/E N/A 
Day Low $2.85    EPS
Volume 959,166